United States Biotechnology & Medical Research

Adamas Pharmaceuticals Inc (ADMS)

Track

Ticker: ADMS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Shreedhar Vijay
Chief Commercial Officer
1 sale — total 31,983 USD
Planned sale 21 Jun 2021
Value US$3,342,443.08 | Price 133.96 | Shares 20,347
Planned sale 7 Jun 2021
Value US$2,895,987.91 | Price 43.62 | Shares 92,982
Sale 22 Mar 2021
Value US$13,272.56 | Price 5.48 | Shares 2,422
Sale 22 Mar 2021
Value US$5,780.50 | Price 5.50 | Shares 1,051
Buy 11 Mar 2021
Value US$30,233.50 | Price 5.06 | Shares 5,975
Sale 1 Feb 2021
Value US$24,301.56 | Price 6.36 | Shares 3,821
Planned sale 1 Feb 2021
Value US$28,844.46 | Price 6.39 | Shares 4,514
Sale 20 Jan 2021
Value US$11,598.30 | Price 4.41 | Shares 2,630
Sale 2 Nov 2020
Value US$6,580.50 | Price 3.21 | Shares 2,050
Sale 21 Jan 2020
Value US$7,512.48 | Price 5.92 | Shares 1,269
Sale 20 Sep 2019
Value US$10,945.44 | Price 6.91 | Shares 1,584
Sale 22 Jul 2019
Value US$6,492.00 | Price 6.00 | Shares 1,082
Planned sale 20 Jun 2019
Value US$5,029.00 | Price 5.35 | Shares 940
Sale 20 Mar 2019
Value US$50,488.81 | Price 7.99 | Shares 6,319
Sale 20 Mar 2019
Value US$14,318.08 | Price 7.99 | Shares 1,792
Sale 20 Mar 2019
Value US$6,847.43 | Price 7.99 | Shares 857
Sale 20 Mar 2019
Value US$9,480.00 | Price 8.00 | Shares 1,185
Sale 20 Mar 2019
Value US$18,992.00 | Price 8.00 | Shares 2,374
Planned sale 20 Dec 2018
Value US$1,712.28 | Price 7.51 | Shares 228
Planned sale 20 Dec 2018
Value US$3,196.00 | Price 7.52 | Shares 425
Buy 7 Nov 2018
Value US$49,956.44 | Price 12.98 | Shares 3,850
Sale 21 Sep 2018
Value US$31,934.70 | Price 19.18 | Shares 1,665
Planned sale 21 Jun 2018
Value US$25,530.96 | Price 25.48 | Shares 1,002
Planned sale 21 Jun 2018
Value US$63,725.48 | Price 25.48 | Shares 2,501
Sale 21 Mar 2018
Value US$25,423.98 | Price 25.89 | Shares 982
Sale 21 Mar 2018
Value US$116,930.75 | Price 25.75 | Shares 4,541
Sale 21 Mar 2018
Value US$14,730.66 | Price 25.98 | Shares 567
Sale 21 Mar 2018
Value US$32,476.88 | Price 25.94 | Shares 1,252
Planned sale 21 Dec 2017
Value US$14,212.00 | Price 32.30 | Shares 440
Planned sale 21 Jun 2017
Value US$18,253.73 | Price 17.53 | Shares 1,041
Sale 21 Jun 2017
Value US$174,365.00 | Price 17.44 | Shares 10,000
Sale 20 Jun 2017
Value US$346,934.00 | Price 17.35 | Shares 20,000
Sale 19 Jun 2017
Value US$5,967,675.00 | Price 17.05 | Shares 350,000
Sale 21 Mar 2017
Value US$12,490.32 | Price 17.04 | Shares 733
Sale 21 Mar 2017
Value US$47,803.21 | Price 17.03 | Shares 2,807
Sale 21 Mar 2017
Value US$12,186.32 | Price 17.02 | Shares 716
Buy 16 Sep 2016
Value US$138,497.10 | Price 16.81 | Shares 8,240
Buy 16 Sep 2016
Value US$138,497.10 | Price 16.81 | Shares 8,240
Buy 15 Sep 2016
Value US$3,300.00 | Price 16.50 | Shares 200
Buy 15 Sep 2016
Value US$3,300.00 | Price 16.50 | Shares 200
Buy 14 Sep 2016
Value US$895,786.59 | Price 16.43 | Shares 54,537
Buy 14 Sep 2016
Value US$895,786.59 | Price 16.43 | Shares 54,537
Buy 13 Sep 2016
Value US$964,994.70 | Price 15.56 | Shares 62,034
Buy 13 Sep 2016
Value US$964,994.70 | Price 15.56 | Shares 62,034
Buy 12 Sep 2016
Value US$349,734.97 | Price 15.65 | Shares 22,342
Buy 12 Sep 2016
Value US$349,734.97 | Price 15.65 | Shares 22,342
Buy 7 Sep 2016
Value US$954,065.28 | Price 15.68 | Shares 60,846
Buy 7 Sep 2016
Value US$954,065.28 | Price 15.68 | Shares 60,846
Buy 6 Sep 2016
Value US$107,979.84 | Price 15.00 | Shares 7,200
Buy 6 Sep 2016
Value US$107,979.84 | Price 15.00 | Shares 7,200
Buy 2 Sep 2016
Value US$644,920.83 | Price 14.75 | Shares 43,719
Buy 2 Sep 2016
Value US$644,920.83 | Price 14.75 | Shares 43,719
Planned sale 18 Apr 2016
Value US$431,679.00 | Price 18.50 | Shares 23,334
Planned sale 18 Apr 2016
Value US$234,321.00 | Price 18.50 | Shares 12,666
Planned sale 8 Jul 2015
Value US$85,408.10 | Price 27.55 | Shares 3,100
Planned sale 8 Jul 2015
Value US$85,408.10 | Price 27.55 | Shares 3,100
Planned sale 5 Jun 2015
Value US$37,900.00 | Price 18.95 | Shares 2,000
Planned sale 29 May 2015
Value US$2,019,555.46 | Price 18.02 | Shares 112,073
Planned sale 29 May 2015
Value US$2,019,555.46 | Price 18.02 | Shares 112,073
Planned sale 14 May 2015
Value US$3,600.00 | Price 18.00 | Shares 200
Planned sale 14 May 2015
Value US$1,800.00 | Price 18.00 | Shares 100
Planned sale 13 May 2015
Value US$1,800.00 | Price 18.00 | Shares 100
Planned sale 13 May 2015
Value US$504.00 | Price 18.00 | Shares 28
Planned sale 12 May 2015
Value US$32,400.00 | Price 18.00 | Shares 1,800
Planned sale 12 May 2015
Value US$9,003.00 | Price 18.01 | Shares 500
Planned sale 5 May 2015
Value US$35,240.00 | Price 17.62 | Shares 2,000
Planned sale 23 Apr 2015
Value US$43,212.00 | Price 18.01 | Shares 2,400
Planned sale 23 Apr 2015
Value US$16,200.00 | Price 18.00 | Shares 900
Planned sale 21 Apr 2015
Value US$32,602.35 | Price 18.00 | Shares 1,811
Planned sale 21 Apr 2015
Value US$17,322.16 | Price 18.01 | Shares 962
Planned sale 20 Apr 2015
Value US$93,601.04 | Price 18.00 | Shares 5,200
Planned sale 20 Apr 2015
Value US$46,980.52 | Price 18.00 | Shares 2,610
Planned sale 14 Apr 2015
Value US$1,800.00 | Price 18.00 | Shares 100
Planned sale 14 Apr 2015
Value US$1,440.00 | Price 18.00 | Shares 80
Planned sale 10 Apr 2015
Value US$9,535.00 | Price 19.07 | Shares 500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-06-23 2021-06-21 PlS Planned sale
Shreedhar Vijay

Chief Commercial Officer

Officer
20,347 +11.0%
133.96
US$3,342,443 		20,347 +11.0% 133.96 US$3,342,443
2021-06-08 2021-06-07 PlS Planned sale
2.5
DEMSKI MARTHA J
Non-Executive Director
92,982 +33.7%
43.62
US$2,895,988 		92,982 +33.7% 43.62 US$2,895,988
2021-03-23 2021-03-22 S Sale
Prentiss Christopher B

Chief Financial Officer

Officer
23,552 -45.9%
168.30
US$1,754,007 		23,552 -45.9% 168.30 US$1,754,007
2021-03-23 2021-03-22 S Sale
Shreedhar Vijay

Chief Commercial Officer

Officer
1,051 -0.6%
5.50
US$5,780 		1,051 -0.6% 5.50 US$5,780
2021-03-15 2021-03-11 B Purchase
2.7
Papapetropoulos Spyridon
Non-Executive Director
5,975 +59.8%
5.06
US$30,234 		5,975 +59.8% 5.06 US$30,234
2021-02-01 2021-02-01 S Sale
Prentiss Christopher B

Chief Financial Officer

Officer
3,821 -5.0%
6.36
US$24,302 		3,821 -5.0% 6.36 US$24,302
2021-02-01 2021-02-01 PlS Planned sale
Shreedhar Vijay

Chief Commercial Officer

Officer
4,514 -4.5%
6.39
US$28,844 		4,514 -4.5% 6.39 US$28,844
2021-01-22 2021-01-20 S Sale
Prentiss Christopher B

Chief Financial Officer

Officer
2,630 -3.3%
4.41
US$11,598 		2,630 -3.3% 4.41 US$11,598
2020-11-02 2020-11-02 S Sale
Prentiss Christopher B

Chief Financial Officer

Officer
2,050 -2.5%
3.21
US$6,580 		2,050 -2.5% 3.21 US$6,580
2020-01-23 2020-01-21 S Sale
Prentiss Christopher B

Chief Financial Officer
1,269 -1.8%
5.92
US$7,512 		1,269 -1.8% 5.92 US$7,512
2019-09-23 2019-09-20 S Sale
MERRIWEATHER ALFRED G

Chief Financial Officer
1,584 -3.2%
6.91
US$10,945 		1,584 -3.2% 6.91 US$10,945
2019-07-23 2019-07-22 S Sale
Prentiss Christopher B

Chief Accounting Officer
1,082 -2.2%
6.00
US$6,492 		1,082 -2.2% 6.00 US$6,492
2019-06-21 2019-06-20 PlS Planned sale
3.4
Rhodes Jennifer J

CBO, GC & Compliance Officer
940 -1.5%
5.35
US$5,029 		940 -1.5% 5.35 US$5,029
2019-03-21 2019-03-20 S Sale
Went Gregory T

Chief Executive Officer

Executive Director
6,319 -3.5%
7.99
US$50,489 		6,319 -3.5% 7.99 US$50,489
2019-03-21 2019-03-20 S Sale
3.4
Rhodes Jennifer J

CBO, GC & Compliance Officer
1,792 -5.4%
7.99
US$14,318 		1,792 -5.4% 7.99 US$14,318
2019-03-21 2019-03-20 S Sale
MERRIWEATHER ALFRED G

Chief Financial Officer
857 -3.4%
7.99
US$6,847 		857 -3.4% 7.99 US$6,847
2019-03-21 2019-03-20 S Sale
Prentiss Christopher B

Chief Accounting Officer
1,185 -3.9%
8.00
US$9,480 		1,185 -3.9% 8.00 US$9,480
2019-03-21 2019-03-20 S Sale
Patni Rajiv

Chief Medical Officer
2,374 -11.0%
8.00
US$18,992 		2,374 -11.0% 8.00 US$18,992
2018-12-26 2018-12-20 PlS Planned sale
Prentiss Christopher B

Chief Accounting Officer

Officer
228 -1.2%
7.51
US$1,712 		228 -1.2% 7.51 US$1,712
2018-12-21 2018-12-20 PlS Planned sale Rhodes Jennifer J

CBO, GC & Compliance Officer

Officer
425 -1.3%
7.52
US$3,196 		425 -1.3% 7.52 US$3,196
2018-11-08 2018-11-07 B Purchase Went Gregory T

Chief Executive Officer

Executive Director
3,850 +2.0%
12.98
US$49,956 		3,850 +2.0% 12.98 US$49,956
2018-09-21 2018-09-21 S Sale
MERRIWEATHER ALFRED G

Chief Financial Officer

Officer
1,665 -6.1%
19.18
US$31,935 		1,665 -6.1% 19.18 US$31,935
2018-06-22 2018-06-21 PlS Planned sale
Rhodes Jennifer J

CBO, GC & Compliance Officer

Officer
1,002 -2.9%
25.48
US$25,531 		1,002 -2.9% 25.48 US$25,531
2018-06-22 2018-06-21 PlS Planned sale KING RICHARD

Chief Operating Officer
2,501 -4.9%
25.48
US$63,725 		2,501 -4.9% 25.48 US$63,725
2018-03-22 2018-03-21 S Sale Rhodes Jennifer J

CBO, GC & Compliance Officer
982 -2.8%
25.89
US$25,424 		982 -2.8% 25.89 US$25,424
2018-03-22 2018-03-21 S Sale
Went Gregory T

Chief Executive Officer

Executive Director
4,541 -2.4%
25.75
US$116,931 		4,541 -2.4% 25.75 US$116,931
2018-03-22 2018-03-21 S Sale
Prentiss Christopher B

Chief Accounting Officer
567 -3.1%
25.98
US$14,731 		567 -3.1% 25.98 US$14,731
2018-03-22 2018-03-21 S Sale Patni Rajiv

Chief Medical Officer
1,252 -5.5%
25.94
US$32,477 		1,252 -5.5% 25.94 US$32,477
2017-12-21 2017-12-21 PlS Planned sale Rhodes Jennifer J

CBO, GC & Compliance Officer
440 -1.5%
32.30
US$14,212 		440 -1.5% 32.30 US$14,212
2017-06-22 2017-06-21 PlS Planned sale
Rhodes Jennifer J

CBO, GC & Compliance Officer
1,041 -3.5%
17.53
US$18,254 		1,041 -3.5% 17.53 US$18,254
2017-06-21 2017-06-21 S Sale GREAT POINT PARTNERS LLC Large shareholder
10,000 -0.4%
17.44
US$174,365 		10,000 -0.4% 17.44 US$174,365
2017-06-21 2017-06-20 S Sale GREAT POINT PARTNERS LLC Large shareholder
20,000 -0.9%
17.35
US$346,934 		20,000 -0.9% 17.35 US$346,934
2017-06-21 2017-06-19 S Sale GREAT POINT PARTNERS LLC Large shareholder
350,000 -13.5%
17.05
US$5,967,675 		350,000 -13.5% 17.05 US$5,967,675
2017-03-22 2017-03-21 S Sale Patni Rajiv

Chief Medical Officer
733 -5.1%
17.04
US$12,490 		733 -5.1% 17.04 US$12,490
2017-03-22 2017-03-21 S Sale
Went Gregory T

Chief Executive Officer

Executive Director
2,807 -1.7%
17.03
US$47,803 		2,807 -1.7% 17.03 US$47,803
2017-03-22 2017-03-21 S Sale DAWSON WILLIAM J

Chief Financial Officer

Officer
716 -4.8%
17.02
US$12,186 		716 -4.8% 17.02 US$12,186
2016-09-16 2016-09-16 B Purchase MDV IX LP Large shareholder
8,240 +0.2%
16.81
US$138,497 		8,240 +0.2% 16.81 US$138,497
2016-09-16 2016-09-16 B Purchase Ericson William W. Non-Executive Director Large shareholder
8,240 +0.2%
16.81
US$138,497 		8,240 +0.2% 16.81 US$138,497
2016-09-16 2016-09-15 B Purchase MDV IX LP Large shareholder
200 +0.0%
16.50
US$3,300 		200 +0.0% 16.50 US$3,300
2016-09-16 2016-09-15 B Purchase Ericson William W. Non-Executive Director Large shareholder
200 +0.0%
16.50
US$3,300 		200 +0.0% 16.50 US$3,300
2016-09-16 2016-09-14 B Purchase MDV IX LP Large shareholder
54,537 +1.4%
16.43
US$895,787 		54,537 +1.4% 16.43 US$895,787
2016-09-16 2016-09-14 B Purchase Ericson William W. Non-Executive Director Large shareholder
54,537 +1.4%
16.43
US$895,787 		54,537 +1.4% 16.43 US$895,787
2016-09-14 2016-09-13 B Purchase Ericson William W. Non-Executive Director Large shareholder
62,034 +1.6%
15.56
US$964,995 		62,034 +1.6% 15.56 US$964,995
2016-09-14 2016-09-13 B Purchase MDV IX LP Large shareholder
62,034 +1.6%
15.56
US$964,995 		62,034 +1.6% 15.56 US$964,995
2016-09-14 2016-09-12 B Purchase Ericson William W. Non-Executive Director Large shareholder
22,342 +0.6%
15.65
US$349,735 		22,342 +0.6% 15.65 US$349,735
2016-09-14 2016-09-12 B Purchase MDV IX LP Large shareholder
22,342 +0.6%
15.65
US$349,735 		22,342 +0.6% 15.65 US$349,735
2016-09-09 2016-09-07 B Purchase MDV IX LP Large shareholder
60,846 +1.6%
15.68
US$954,065 		60,846 +1.6% 15.68 US$954,065
2016-09-09 2016-09-07 B Purchase Ericson William W. Non-Executive Director Large shareholder
60,846 +1.6%
15.68
US$954,065 		60,846 +1.6% 15.68 US$954,065
2016-09-07 2016-09-06 B Purchase Ericson William W. Non-Executive Director Large shareholder
7,200 +0.2%
15.00
US$107,980 		7,200 +0.2% 15.00 US$107,980
2016-09-07 2016-09-06 B Purchase MDV IX LP Large shareholder
7,200 +0.2%
15.00
US$107,980 		7,200 +0.2% 15.00 US$107,980
2016-09-07 2016-09-02 B Purchase Ericson William W. Non-Executive Director Large shareholder
43,719 +1.2%
14.75
US$644,921 		43,719 +1.2% 14.75 US$644,921
2016-09-07 2016-09-02 B Purchase MDV IX LP Large shareholder
43,719 +1.2%
14.75
US$644,921 		43,719 +1.2% 14.75 US$644,921
2016-04-20 2016-04-18 PlS Planned sale McClure Natalie

SVP, Product Development

Officer
23,334 -73.7%
18.50
US$431,679 		23,334 -73.7% 18.50 US$431,679
2016-04-20 2016-04-18 PlS Planned sale McClure Natalie

SVP, Product Development

Officer
12,666 -60.3%
18.50
US$234,321 		12,666 -60.3% 18.50 US$234,321
2015-07-09 2015-07-08 PlS Planned sale MDV IX LP Large shareholder
3,100 -1.0%
27.55
US$85,408 		3,100 -1.0% 27.55 US$85,408
2015-07-09 2015-07-08 PlS Planned sale Ericson William W. Non-Executive Director Large shareholder
3,100 -1.0%
27.55
US$85,408 		3,100 -1.0% 27.55 US$85,408
2015-06-09 2015-06-05 PlS Planned sale McClure Natalie

SVP, Product Development

Officer
2,000 -70.4%
18.95
US$37,900 		2,000 -70.4% 18.95 US$37,900
2015-06-01 2015-05-29 PlS Planned sale Ericson William W. Non-Executive Director Large shareholder
112,073 -24.7%
18.02
US$2,019,555 		112,073 -24.7% 18.02 US$2,019,555
2015-06-01 2015-05-29 PlS Planned sale MDV IX LP Large shareholder
112,073 -24.7%
18.02
US$2,019,555 		112,073 -24.7% 18.02 US$2,019,555
2015-05-14 2015-05-14 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
200 -0.1%
18.00
US$3,600 		200 -0.1% 18.00 US$3,600
2015-05-14 2015-05-14 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
100 -0.3%
18.00
US$1,800 		100 -0.3% 18.00 US$1,800
2015-05-14 2015-05-13 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
100 -0.0%
18.00
US$1,800 		100 -0.0% 18.00 US$1,800
2015-05-14 2015-05-13 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
28 -0.1%
18.00
US$504 		28 -0.1% 18.00 US$504
2015-05-14 2015-05-12 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
1,800 -0.5%
18.00
US$32,400 		1,800 -0.5% 18.00 US$32,400
2015-05-14 2015-05-12 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
500 -2.4%
18.01
US$9,003 		500 -2.4% 18.01 US$9,003
2015-05-07 2015-05-05 PlS Planned sale McClure Natalie

SVP, Product Development

Officer
2,000 -70.4%
17.62
US$35,240 		2,000 -70.4% 17.62 US$35,240
2015-04-27 2015-04-23 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
2,400 -0.6%
18.01
US$43,212 		2,400 -0.6% 18.01 US$43,212
2015-04-27 2015-04-23 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
900 -4.3%
18.00
US$16,200 		900 -4.3% 18.00 US$16,200
2015-04-22 2015-04-21 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
1,811 -0.5%
18.00
US$32,602 		1,811 -0.5% 18.00 US$32,602
2015-04-22 2015-04-21 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
962 -4.6%
18.01
US$17,322 		962 -4.6% 18.01 US$17,322
2015-04-22 2015-04-20 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
5,200 -1.3%
18.00
US$93,601 		5,200 -1.3% 18.00 US$93,601
2015-04-22 2015-04-20 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
2,610 -11.5%
18.00
US$46,981 		2,610 -11.5% 18.00 US$46,981
2015-04-14 2015-04-14 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
100 -0.0%
18.00
US$1,800 		100 -0.0% 18.00 US$1,800
2015-04-14 2015-04-14 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
80 -0.8%
18.00
US$1,440 		80 -0.8% 18.00 US$1,440
2015-04-14 2015-04-10 PlS Planned sale Went Gregory T

Chief Executive Officer

Executive Director Large shareholder
500 -0.1%
19.07
US$9,535 		500 -0.1% 19.07 US$9,535
Explore more

More insider trading research around Adamas Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America